Top compounds associated with response to IRF5


Feature Type Standardized
Nominal ANOVA
mRNA decitabine CTRPv2 pan-cancer AAC -0.23 2e-15
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 1e-08
mRNA BHG712 GDSC1000 pan-cancer AAC -0.16 1e-06
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.19 1e-06
mRNA 5-FU CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.19 3e-06
mRNA NG-25 GDSC1000 pan-cancer AAC -0.15 9e-06
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.14 2e-05
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.17 2e-05
mRNA TL-1-85 GDSC1000 pan-cancer AAC -0.14 2e-05
Download CSV